Parkinson's Needs FDA Flexibility, NIH Funding Certainty
This article was originally published in Scrip
Executive Summary
With Parkinson's affecting about six million people worldwide – with some estimates putting it as high as 10 million – and the condition becoming increasingly burdensome on health systems around the globe, "we don't have to do a lot of convincing" the disease is worthwhile to invest in and pursue for new treatments, said Todd Sherer, CEO of the Michael J. Fox Foundation (MJFF).